论文部分内容阅读
随着人们生活水平的提高,生活方式的改变,中老年人糖尿病发病率越来越高,其中2型糖尿病的比例更高达90%以上。目前临床上治疗2型糖尿病的药物主要有胰岛素及其类似物注射剂、磺酰脲类促胰岛素分泌剂、非磺酰脲类促胰岛素分泌剂、双胍类、α-糖苷酶抑制药和胰岛素增敏剂。阿卡波糖是从放线菌培养液中分离得到的具有α-糖苷酶抑制作用的伪寡糖类,主要通过降低多糖及蔗糖分解生成
As people’s living standards improve, lifestyle changes, the incidence of diabetes in the elderly is getting higher and higher, of which the proportion of type 2 diabetes more than 90%. The current clinical treatment of type 2 diabetes drugs mainly insulin and its analogs injection, sulfonylurea insulin secretagogue, non-sulfonylurea insulin secretagogues, biguanides, α-glucosidase inhibitors and insulin sensitization Agent. Acarbose is isolated from actinomycetes culture medium with α-glucosidase inhibition of pseudo-oligosaccharides, mainly through the reduction of polysaccharides and sucrose decomposition